ArticleHemaSphere2022
Azacytidine and Venetoclax in Relapsed and Refractory Patients With Angioimmunoblastic T-cell Lymphoma.
Kamel Laribi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleHemaSphere2022
Kamel Laribi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.